Literature DB >> 22697152

Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline.

N Wickham1, A S Gallus, B N J Walters, A Wilson.   

Abstract

Each year in Australia, about 1 in 1000 people develop a first episode of venous thromboembolism (VTE), which approximates to about 20,000 cases. More than half of these episodes occur during or soon after a hospital admission, which makes them potentially preventable. This paper summarises recommendations from the National Health and Medical Research Council's 'Clinical Practice Guideline for the Prevention of Venous Thromboembolism in Patients Admitted to Australian Hospitals' and describes the way these recommendations were developed. The guideline has two aims: to provide advice on VTE prevention to Australian clinicians and to support implementation of effective programmes for VTE prevention in Australian hospitals by offering evidence-based recommendations which local hospital guidelines can be based on. Methods for preventing VTE are pharmacological and/or mechanical, and they require appropriate timing, dosing and duration and also need to be accompanied by good clinical care, such as promoting mobility and hydration whilst in hospital. With some procedures or injuries, the risk of VTE is sufficiently high to require that all patients receive an effective form of prophylaxis unless this is contraindicated; in other clinical settings, the need for prophylaxis requires individual assessment. For optimal VTE prevention, all patients admitted to hospital should have early and formal assessments of: (i) their intrinsic VTE risk and the risks related to their medical conditions; (ii) the added VTE risks resulting from surgery or trauma; (iii) bleeding risks that would contraindicate pharmacological prophylaxis; (iv) any contraindications to mechanical prophylaxis, culminating in (v) a decision about prophylaxis (pharmacological and/or mechanical, or none). The most appropriate form of prophylaxis will depend on the type of surgery, medical condition and patient characteristics. Recommendations for various clinical circumstances are provided as summary tables with relevance to orthopaedic surgical procedures, other types of surgery and medical inpatients. In addition, the tables indicate the grades of supporting evidence for the recommendations (these range from Grade A which can be trusted to guide practice, to Grade D where there is more uncertainty; Good Practice Points are consensus-based expert opinions).
© 2012 National Health and Medical Research Council. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22697152     DOI: 10.1111/j.1445-5994.2012.02808.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  12 in total

Review 1.  The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines.

Authors:  Cristhiam M Rojas-Hernandez
Journal:  Support Care Cancer       Date:  2017-11-29       Impact factor: 3.603

Review 2.  Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review.

Authors:  Hanno Riess; Piet Habbel; Anja Jühling; Marianne Sinn; Uwe Pelzer
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 3.  Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials.

Authors:  Cristhiam M Rojas-Hernandez; Thein Hlaing Oo
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

4.  Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center.

Authors:  Maliha Khan; Travis M Cox; Mohammed Nassif; Mohanad A Alzubaidi; Naveen Garg; Wei Qiao; Fleur M Aung; Thein Hlaing Oo; Cristhiam M Rojas-Hernandez
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

5.  Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study.

Authors:  Alhossain A Khalafallah; Brooke E Kirkby; Sophia Wong; Yi Chao Foong; Nishant Ranjan; James Luttrell; Ronnie Mathew; Charles M Chilvers; Emily Mauldon; Colin Sharp; Terry Hannan
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

6.  Critical appraisal of international guidelines for the prevention and treatment of pregnancy-associated venous thromboembolism: a systematic review.

Authors:  Jie Zheng; Qinchang Chen; Jing Fu; Yanling Lu; Tianjun Han; Ping He
Journal:  BMC Cardiovasc Disord       Date:  2019-08-16       Impact factor: 2.298

7.  Chinese orthopaedic nurses' knowledge, attitude and venous thromboembolic prophylactic practices: A multicentric cross-sectional survey.

Authors:  Yu Wang; Xin-Juan Wu; Yu-Fen Ma; Yuan Xu; Xiao-Jie Wang; Chen Zhu; Jing Cao; Jing Jiao; Ge Liu; Zhen Li; Ying Liu; Li-Yun Zhu
Journal:  J Clin Nurs       Date:  2021-01-31       Impact factor: 3.036

8.  Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines.

Authors:  Soo-Mee Bang; Moon Ju Jang; Kyoung Ha Kim; Ho-Young Yhim; Yeo-Kyeoung Kim; Seung-Hyun Nam; Hun Gyu Hwang; Sung Hwa Bae; Sung-Hyun Kim; Yeung-Chul Mun; Yang-Ki Kim; Inho Kim; Won-Il Choi; Chul Won Jung; Nan Hee Park; Nam-Kyong Choi; Byung-Joo Park; Doyeun Oh
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

9.  Muscle activity in the lower limbs during push-down movement with a new active-exercise apparatus for the leg.

Authors:  Kenta Tanaka; Hiroshi Kamada; Yukiyo Shimizu; Shizu Aikawa; Shun Irie; Naoyuki Ochiai; Masataka Sakane; Masashi Yamazaki
Journal:  J Phys Ther Sci       Date:  2016-03-31

10.  Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia.

Authors:  Fahad M Al-Hameed; Hasan M Al-Dorzi; Abdulelah I Qadhi; Amira Shaker; Farjah H Al-Gahtani; Fawzi F Al-Jassir; Galila F Zahir; Tarig S Al-Khuwaitir; Mohammed H Addar; Mohamed S Al-Hajjaj; Mohamed A Abdelaal; Essam Y Aboelnazar
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.